GlassScriptPhysician profile
Paul Gursky
NPI 1770161267
$700.11
in general payments reported to CMS, 2019-2025
13 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $107 · 2024: $177 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $685 · Education: $15.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.68 |
| Education | $15.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $176.78 | 2024 | Irrisept |
| Glaxosmithkline, LLC. | $142.28 | 2025 | Benlysta |
| Angiodynamics, INC. | $90.91 | 2023 | Auryon Laser System 100-120 Vac |
| Mallinckrodt Hospital Products INC. | $54.46 | 2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.49 | 2025 | |
| Ucb, INC. | $39.04 | 2023-2025 | Bimzelx, Cimzia |
| Astrazeneca Pharmaceuticals LP | $31.99 | 2025 | Saphnelo |
| Genzyme Corporation | $31.01 | 2025 | |
| Novartis Pharmaceuticals Corporation | $22.20 | 2025 | |
| Calliditas Therapeutics US INC. | $21.19 | 2025 | Tarpeyo |
| Amgen INC. | $20.10 | 2025 | Tavneos |
| Opko Pharmaceuticals, LLC | $15.43 | 2025 | Rayaldee |
| Kyowa Kirin, INC. | $14.23 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Gursky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.